Adverse allergic reaction to technetium-99m methylene diphosphonate.
Adverse allergic reactions to radiopharmaceuticals are rare but have been documented in the literature. This report presents data consistent with a definite adverse reaction to the radiopharmaceutical [99mTc]MDP.
Spicer
J A
JA
Preston
D F
DF
Stephens
R L
RL
D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D001943:Breast Neoplasms / Q000000981:diagnostic imaging; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000000981:diagnostic imaging; D004164:Diphosphonates / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008875:Middle Aged; D011877:Radionuclide Imaging; D013667:Technetium / Q000009:adverse effects*; D013669:Technetium Tc 99m Medronate; D013997:Time Factors
D004164:Diphosphonates; D013667:Technetium; D013669:Technetium Tc 99m Medronate